Scott explores GABA-A receptor subunits, their effects, and how various drugs interact with them, discussing potential for more selective drug development. Longer summary

This post explores GABA-A receptor subunits and their role in psychiatric drugs and supplements. It explains the structure of GABA-A receptors, focusing on the alpha subunits and their associated effects. The post discusses how different drugs like benzodiazepines and zolpidem (Ambien) interact with these subunits, and mentions attempts to create more selective drugs. It also touches on the role of GABA receptors in alcohol's effects and the classification of Z-drugs. The author includes personal experiences with supplements claiming to have selective GABA modulation. Shorter summary

Scott Alexander examines Zulresso and Zuranolone, two neurosteroid drugs for postpartum depression, discussing their efficacy, challenges, and potential future applications. Longer summary

Scott Alexander discusses Zulresso (allopregnanolone) and Zuranolone, two related drugs for treating postpartum depression. He explains their mechanisms, efficacy, and the challenges in their development and usage. The post covers the history of allopregnanolone research, its connection to GABA and hormones, clinical trials, and potential future applications. Scott also discusses the high cost of Zulresso, its limited availability, and the mixed results of Zuranolone in treating regular depression and anxiety. The post ends with predictions about the future of these drugs and related research. Shorter summary